期刊文献+

靶向树突状细胞表面分子DEC-205长循环免疫脂质体稳定性模型的构建及其生物学特性 被引量:1

Stability model construction of long-circulating immunoliposome targeting to dendritic cell surface molecule DEC-205 and analysis of its biological charac teristics
下载PDF
导出
摘要 应用多相分散体系的动力稳定性和聚结稳定性理论,以薄膜分散法构建了靶向树突状细胞(dendritic cells,DCs)表面分子DEC-205长循环免疫脂质体(anti-DEC-205 iLPSM)的稳定性模型,并对其物理稳定性、生物学特性等进行了考察。结果表明经优化后的脂质体4℃贮存7d后粒径分布变化较小;FITC-dextran累积泄漏率小于7%;耦联抗DEC-205的免疫脂质体(anti-DEC-205 iLPSM)可特异性地识别DCs,并作为良好载体将FITC-dextran带入DCs浆内。anti-DEC-205 iLPSM模型的构建为进一步研究抗原靶向DEC-205受体后的体内免疫应答情况提供了工作基础,有望开发一种新型DCs疫苗应用于临床。 To enable the liposome to deliver encapsulated drugs or antigen to dendritic cells efficiently and induce strong T cell immune response or specific immune tolerance, the hposomes containing FTTC- dextran were prepared by film dispersion; DSPE- PEG(2000) was used to modify the liposome membrane so that it has a long circulatory function; SPDP, heterotypic Dual-functional crosslinker, was used to conjugate the mouse DEC- 205 antibodies to the hposomes so that the modified liposomes could target DCs. The optimized liposomes showed stable physicochemical properties when stored at 4℃ for 7 days. Under this condition, liposome size and size distribution did not noticeably change. Cumulative leakage rate of FTTC - dextran from liposomes was less than 7 %. Anti - DEC - 205 - immunoliposomes ( anti - DEC - 205 iLPSM), as drug carriers, can specifically recognize dendritic cells and dehver FTTC - dextran into the cytoplasm. The construction of an anti - DEC - 205 iLPSM model lays solid foundations for further work researching immune response after antigen targeting to DEC - 205 receptors in vivo. Anti - DEC - 205 iLPSM could become a new type of DC vaccine.
出处 《生物信息学》 2009年第2期104-107,共4页 Chinese Journal of Bioinformatics
关键词 免疫脂质体 树突状细胞 DEC-205 稳定性模型 Immunoliposome, Dendritic cells, DEC - 205, Stability model
  • 相关文献

参考文献10

  • 1Kato M., McDonald K. J., et al., Expression of human DEC - 205 (CD205) muhilectin receptor on leukocytes[J]. Int Immunol., 2006, 18(6) : 857 - 869.
  • 2Badiee A., Davies N., McDonald K., et al., Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC - 205[J]. Vaccine,2007,25(25) :4757 - 4766.
  • 3Bozzacco L., Trumpfheller C., Siegal F. P., et al., DEC- 205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes [ J ]. Proc Natl Acad Sci USA, 2007,104(4):1289- 1294.
  • 4Bonifaz L.C., Bonnyay D.P., Charalambous A., et al., In vivo tarsgeting of antigens to maturing dendritic cells via the DEC - 205 receptor Improves W cell vaccination[ J]. J Exp Med, 2004, 199(6): 815 - 824.
  • 5Hawiger D., Inaba K., Dorsett Y., et al., Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo [J] .J Exp Med,2001,194(6):769 - 779.
  • 6Torchilin V.P., Rammohan R., Weissig V., et al., TAT peptide on the surface of liposomes affords their efficient intmcellular delivery even at low temperature and in the presence of metabohc inhibitors [J]. Proc Nail Acad Sci USA,2001,98(15) :8786 - 8791.
  • 7Dian R., Arifin, Andre F., Stability of Liposome Encapsulated Hemoglobin Dispersions, Palmer Artificial Cells [ J ]. Blood Substitutes, and Biotechnology, 2005, 33:113- 136.
  • 8Lutz M. B., Kukutsch N., Ogilvie A.L., et al., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow[ J]. J lmmunol Methods, 1999,223 (1):77 - 92.
  • 9Ignatius R., Mahnke K., Rivera M., et al. Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8( + ) T- cell responses in vivo[ J] .Blood, 2000,96:3505 - 3513.
  • 10DENG Ying- Jie. Liposome Technology[M]. Beijing: People's Medical Publishings House,2007:112- 114.

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部